ART Cycles Linked to Slight Increase in Cardiovascular Risk, Suggests Research We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
New Book on Hypertension Launched During The 77th Annual Conference of Cardiology Society Of India We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Cuffless BP technologies in wearable devices show promise to transform care: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Medical Bulletin 15/December/2025 We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Diabetes, Obesity, and Hypertension Linked to Higher Risk of Aggressive Prostate Cancer: Meta-Analysis Shows We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Long-term benefits of daily multivitamin use may vary by diet quality and baseline BP: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
New Meta-Analysis Identifies Emerging Risk Factors for Postherpetic Neuralgia We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
How Hydralazine Inhibits Growth of Glioblastoma, Study Sheds Light We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a review of the highly anticipated drug, and AZ is using a priority review voucher to shorten the timeline for a potential approval to the second…
Early Addition of Trimetazidine to First-Line Standard of Care Rapidly Improves Symptoms and Quality of Life in Recently Diagnosed Stable Angina Patients: The COMBINE- Angina Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our…